Dermal Cell News 6.01 January 13, 2020 | |
| |
TOP STORYHigh ROCK-myosin II activity correlated with aggressiveness, identifying targeted therapy- and immunotherapy-resistant melanomas. Survival of resistant cells was myosin II dependent, regardless of the therapy. [Cancer Cell] Full Article | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)DERMAL STEM CELLS & TISSUE REGENERATIONADAR1 Mediated Regulation of Neural Crest Derived Melanocytes and Schwann Cell Development Researchers report that adenosine deaminase acting on RNA (ADAR1), responsible for adenosine-to-inosine editing of RNA, was required for regulating the development of two neural crest derivatives: melanocytes and Schwann cells. [Nat Commun] Full Article Epidermal Autonomous VEGFA/Flt1/Nrp1 Functions Mediate Psoriasis-Like Disease Investigators showed that conditional deletion of Flt1 or Nrp1 in epidermal cells inhibited psoriasis mediated by Vegfa overexpression or c-Jun/JunB deletion. Administration of anti-Nrp1 antibody reverted the psoriasis phenotype. [Sci Adv] Full Article The authors constructed two reporter genes carrying the ADAR1 5’untranslated region sequence with/without the variant between the PGK promoter and a luciferase coding sequence, and performed luciferase assays, semi-quantitative PCR analyses and polysomal assays. [Pigment Cell Melanoma Res] Abstract Scientists demonstrated that piperlongumine treatment effectively abrogated the hyperproliferation and differentiation of keratinocytes by inducing ROS-mediated late apoptosis with loss of mitochondrial membrane potential. [Cell Death Dis] Full Article Knockdown of Sodium Channel Nax Reduces Dermatitis Symptoms in Rabbit Skin Investigators found that in vivo knockdown of Nax using RNAi reduced hyperkeratosis and keratinocyte hyperproliferation in rabbit ear dermatitic skin. Increased infiltration of inflammatory cells, a characteristic of dermatitis, was reduced by Nax knockdown. [Lab Invest] Abstract SKIN CANCERS & DISORDERSEpigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis Scientists investigated the role of circular RNAs in metastasis, using melanoma as a model aggressive tumor. They identified silencing of cerebellar degeneration-related 1 antisense, a regulator of miR-7, as a hallmark of melanoma progression. [Cancer Cell] Abstract | Graphical Abstract CSF samples were analyzed by mass spectrometry and incubated with melanoma cells, that were subjected to RNA-Seq analysis. Functional assays were performed to validate the pathways identified. [Clin Cancer Res] Abstract Researchers used a skin carcinogenesis model, which showed early tumor initiation in Sfrp1 knockout mice and increased tumorigenic potential of Sfrp1 knockout cancer stem cells. [Stem Cell Reports] Full Article The TERT Copy Number Gain Is Sensitive to Telomerase Inhibitors in Human Melanoma The sensitivity to telomerase inhibitors was evaluated in cell lines and patient-derived xenograft models with or without telomerase reverse transcriptase (TERT) copy number gain. [Clin Sci (Lond)] Abstract Subscribe to one of our other 19 science newsletters such as Extracellular Matrix News & Cancer Stem Cell News. | |
| |
REVIEWSLifting the Veil on the Keratinocyte Contribution to Cutaneous Nociception The authors highlight recent and relevant findings on the cellular and molecular elements that underlie the contribution of epidermal keratinocytes as nociceptive modulators and noxious sensors, both under healthy and pathological conditions. [Protein Cell] Full Article Visit our reviews page to see a complete list of reviews in the dermal cell research field. | |
| |
INDUSTRY NEWSNektar Therapeutics and Bristol-Myers Squibb Company announced the companies have agreed to a new joint development plan to advance bempegaldesleukin plus Opdivo into multiple new registrational trials. [Nektar Therapeutics, Inc.] Press Release Connect Biopharma announced positive topline data from the Phase Ib study of its novel IL-4Rα antibody, CBP-201, in patients with moderate-to-severe atopic dermatitis. [Connect Biopharma] Press Release | |
| |
POLICY NEWSFDA and NIH Let Clinical Trial Sponsors Keep Results Secret and Break the Law For 20 years, the US government has urged companies, universities, and other institutions that conduct clinical trials to record their results in a federal database, so doctors and patients can see whether new treatments are safe and effective. Few trial sponsors have consistently done so, even after a 2007 law made posting mandatory for many trials registered in the database. [ScienceInsider] Editorial Predatory-Journal Papers Have Little Scientific Impact Papers published in ‘predatory’ journals attract little attention from scientists, and get cited much less than those in reputable publications, an analysis shows. Predatory journals are those that charge authors high article-processing fees but don’t provide expected publishing services, such as peer review or other quality checks. [Nature News] Editorial UT Austin Releases Report of 17 Employee Sexual Misconduct Cases Officials from the University of Texas at Austin released a report Thursday, January 10 detailing 17 cases of employee sexual misconduct that took place between November 2017 and December 2019, including three faculty members and one research fellow. The allegations ranged in severity from failing to disclose a consensual relationship with a graduate student, to repeated unwelcome comments, to stalking both on- and off-campus. [The Scientist] Editorial
| |
EVENTSNEW The Microbiome and Viruses Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Research Fellow – Inherited Skin Conditions (University College London) NEW Postdoctoral Fellow – Cancer Biology (Oklahoma Medical Research Foundation) Postdoctoral Position – Microbiota and Autoimmunity (The University of Arizona) Chief Position – Allergy, Immunology, Rheumatology and Dermatology (Harvard Medical School) Senior Associate Researcher – Inflammatory Skin Diseases (Icahn School of Medicine at Mount Sinai) Postdoctoral Position – RNA Binding Activity of Glycolytic Enzymes in Melanoma (Institut Curie) Postdoctoral Training Fellow – Tumor Heterogeneity (Institute of Cancer Research) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Dermal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
“>Abstract |